Knowledge Center
Article / Jun 08, 2009
Hovione Shapes China Manufacturing Site
Source:
C&EN, 8 June, 2009
Hovione may have made itself a name as a first-class manufacturer of regulated active pharmaceutical ingredients (APIs), but it still needs to compete on price for some of its business. As in many industries, one of the best ways to lower cost is to have a manufacturing base in China. That is what Hovione did in March 2008 when it acquired a 75% stake in Hisyn Pharmaceutical, an API manufacturer in Taizhou, Zhejiang province. The site is a four-hour drive from Shanghai.
Related links
Also in the Knowledge Center
/ Oct 06, 2020
Production of Lysozyme-PLGA-Loaded Microparticles for Controlled Release Using Hot-Melt Extrusion
Read more
Scientific Article
Scientific Article
/ Oct 18, 2021
Ring Shear Tester: The importance of Shear and Wall Friction Methodology for Arching Tendency Predictions
Read more
Scientific Article